Novartis Institutes for BioMedical Research Inc. 13D/13G Filings for Surface Oncology, Inc. (SURF)

Novartis Institutes for BioMedical Research Inc. 13D and 13G filings for Surface Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-08
5:24 pm
Unchanged
2020-12-3113GSurface Oncology, Inc.
SURF
Novartis Institutes for BioMedical Research Inc.3,948,482
9.710%
0
(Unchanged)
Filing